Universal-Beteiligungs- und Servicegesellschaft’s Sage Therapeutics SAGE Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,600	Closed	-$233K	–	2152
2025 Q2	$233K	Buy	+25,600	New	+$188K	﹤0.01%	1894

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's SAGE Position: Q3 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 25,600 shares — an estimated $233K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $233K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 25,600 Sage Therapeutics shares in Q3 2025, an estimated $233K.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
Universal-Beteiligungs- und Servicegesellschaft's Sage Therapeutics position peaked at $233K in Q2 2025.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q3 2025, filed 30 Oct 2025.